Skip to content
MedsAcross

Medicine

Varenicline 0.5 mg tablet

Varenicline · Oral
Available on requestPrescription onlyUS FDAGeneric name

Varenicline 0.5 mg tablet is a generic prescription medicine for oral use, made by 24 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…

Key facts

Active ingredient (INN)
Varenicline
Brand
Sold under the generic name
Strength
0.5 mg
Dosage form
Tablet
Route
Oral
Packs
56 tablets, 60 blister pack, 50 blister pack and 25 more
Manufacturers
Umedica LaboratoriesIndiaZydus LifesciencesIndiaAjanta PharmaIndiaAscend LaboratoriesIndiaAurobindo PharmaIndiaCamber PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaGlenmark PharmaceuticalsIndiaIndoco RemediesIndiaMacleods PharmaceuticalsIndia24 labelers on the register
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N07BA03 Varenicline
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
21 September 2021
Identifiers
RxCUI 636671, 636676, 749289 +1DailyMed set ID 2f86bb7b-c6a6-4915-8ba1-17251540971c, 1297c291-da28-4a73-9c28-d5adee36d7b7, 7bd1abc8-2689-496b-b3f2-1cefe218ff5a +25NDC 27241-173, 0904-7413, 31722-678 +26Application ANDA213019, ANDA214557, ANDA214571 +13

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
56 tablet, film coated in 1 bottle70710-1613-6Zydus LifesciencesIndia13 June 2023
56 tablet, film coated in 1 bottle70771-1773-6Zydus LifesciencesIndia13 June 2023
56 tablet, film coated in 1 bottle27241-173-56Ajanta PharmaIndia31 January 2024
56 tablet, film coated in 1 bottle67877-743-95Ascend LaboratoriesIndia25 August 2023
56 tablet, film coated in 1 bottle59651-417-56Aurobindo PharmaIndia2 May 2025
56 tablet, film coated in 1 bottle31722-678-56Camber PharmaceuticalsIndia23 October 2023
56 tablet, film coated in 1 bottle43598-907-56Dr. Reddy's LaboratoriesIndia13 December 2024
56 tablet, film coated in 1 bottle68462-893-56Glenmark PharmaceuticalsIndia22 August 2023
56 tablet, film coated in 1 bottle14445-153-56Indoco RemediesIndia1 November 2024
56 tablet, film coated in 1 bottle33342-489-19Macleods PharmaceuticalsIndia10 December 2024
56 tablet, film coated in 1 bottle42571-459-82Micro LabsIndia1 December 2025
56 tablet in 1 bottle60290-077-01Umedica LaboratoriesIndia9 January 2026
60 blister pack in 1 carton / 1 tablet in 1 blister pack60290-077-02Umedica LaboratoriesIndia9 January 2026
56 tablet, film coated in 1 bottle60505-3613-5Apotex30 January 2023
56 tablet, film coated in 1 bottle71921-308-56Florida Pharmaceutical Products1 November 2024
56 tablet, film coated in 1 bottle85742-015-15Kanchan Healthcare1 October 2023
56 tablet, film coated in 1 bottle69315-402-56Leading Pharma1 October 2023
56 tablet, film coated in 1 bottle49884-155-76Par Health21 September 2021
56 tablet, film coated in 1 bottle50090-6447-0A-S Medication Solutions20 April 2023
56 tablet, film coated in 1 bottle50090-7135-0A-S Medication Solutions19 April 2024
56 tablet, film coated in 1 bottle50090-7996-0A-S Medication Solutions17 June 2026
56 tablet, film coated in 1 bottle50090-8088-0A-S Medication Solutions21 September 2026
56 tablet, film coated in 1 bottle42291-927-56AvKARE14 September 2023
56 tablet, film coated in 1 bottle72162-2218-2Bryant Ranch Prepack30 January 2023
56 tablet, film coated in 1 bottle0904-7413-35Major Pharmaceuticals18 December 2023
56 tablet, film coated in 1 bottle10135-808-56Marlex Pharmaceuticals1 January 2025
56 tablet, film coated in 1 bottle72603-476-01NorthStar RxLLC23 September 2024
50 blister pack in 1 box / 1 tablet, film coated in 1 blister pack70518-4647-0Remedyrepack29 April 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 10 May 2006Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Varenicline 0.5 mg tablet.

Compare 1

Other strengths and forms of Varenicline

Clinical summary

Varenicline is a partial cholinergic nicotinic agonist indicated as an aid to smoking-cessation treatment. It is available as tablets, kits and nasal spray for oral use. MedsAcross supplies Varenicline for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Varenicline

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Varenicline 0.5 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.